OSCIFLEX LLC

PHILADELPHIA, PA · Medtech · Private

A wearable or external device that modifies blood flow patterns in the legs to activate protective genetic programs in vein endothelial cells and prevent deep vein thrombosis in hospitalized patients.

New patent · Oct 20

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Headquarters: PHILADELPHIA, PA
Total capital: $3.1M

Federal grants: $3.1M; 5 awards · 2019–2021; Rank in peer group#330 of 538
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 1; 5 pending · first 2026; Rank in peer group#237 of 538

Capital timeline

Latest events

Dec 2021Federal grantNSF · Phase II · SBIR Phase II: A portable rapid cycling compression device to prevent blood clots$1.0M
Nov 2021Federal grantHealth and Human S · Phase II · Mechanical device for the prevention of VTE in high risk patient populations$712K
Dec 2020Federal grantHealth and Human S · Phase II · Mechanical device for the prevention of VTE in high risk patient populations$987K
Jun 2019Federal grantHealth and Human S · Phase I · Mechanical generation of peri-valvular oscillatory flow to prevent deep venous thrombosis.$149K
Feb 2019Federal grantNSF · Phase I · SBIR Phase I: VTE mitigation device$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

Federal grantsBelow median
Granted patents#237 · top 44%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 6

Oct 20, 2026New patentRapid Cycling Compression Device for the Prevention of ThrombosisUSPTOUS 12,766,067
May 22, 2025PendingRapid Cycling Compression Device for the Prevention of ThrombosisUSPTOApplication 19029092
Oct 3, 2024PendingRapid Cycling Compression Device for the Prevention of ThrombosisUSPTOApplication 18299272

Show all 6 patent records

Rapid Cycling Compression Device for the Prevention of ThrombosisOct 20, 2026 · US 12,766,067Granted
Rapid Cycling Compression Device for the Prevention of ThrombosisMay 22, 2025 · Application 19029092Pending
Rapid Cycling Compression Device for the Prevention of ThrombosisOct 3, 2024 · Application 18299272Pending
Rapid Cycling Compression Device For The Prevention Of ThrombosisApplication PCTUS2021054927Pending
Rapid Cycling Compression Device for the Prevention of ThrombosisApplication 63209980Pending
Rapid Cycling Compression Device For The Prevention Of ThrombosisApplication 63167603Pending

Angiograft, LLCSimilar federal contract value in Medtech · null in contracts
GELASTOMERICS LLCSimilar federal contract value in Medtech · null in contracts
EASY, LLCSimilar federal contract value in Medtech · null in contracts
CrossComm, Inc.Similar federal contract value in Medtech · null in contracts
Thomas SimonSimilar federal contract value in Medtech · null in contracts
NGS Detectors LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.